03 jun: Nedturen har skabt spændende købsmuligheder
07 jun: NETWORKING – SPILD AF TID ELLER GENVEJEN TIL SUCCES?
06-06-2012 20:51:00

CORRECT: Ahold Suffers From Price Competition in 1Q

("Ahold Suffers From Price Competition in 1Q," at 1:35 a.m. EDT, misstated the Food Lion brand was unprofitable in the 10th paragraph, and in an update at 4:58 a.m. EDT. The correct version follows:)

By Robert van den Oever

AMSTERDAM--Retailer Royal Ahold NV (AH.AE), which runs the Stop & Shop and Giant supermarket chains in the U.S., Wednesday posted a slight fall in first-quarter net profit as intense price competition weighed on margins.

Ahold expects 2012 to be challenging, with price competition continuing and consumer spending under pressure, said Chief Executive Dick Boer, although he added that he's encouraged by the improving sales trend in the second quarter.

The company is outperforming Belgian rival Delhaize Group (DELB.BT) in the U.S., even though its flagship chains have faced fierce competition as retailers battled to lure increasingly price-sensitive customers. Delhaize makes more than half of its sales in the U.S., but Ahold gained market share there during the first quarter with increased promotional activity.

In the Netherlands, which accounts for a third of Ahold's sales, the retailer is suffering from low consumer confidence as shoppers grapple with the government's austerity measures, although it managed to maintain its market share. Its core chain, Albert Heijn, has around 33% market share, which will grow due to the recent acquisition of 82 stores from competitor Jumbo.

In the three months to March 31, Ahold's net profit fell 3.1% to EUR282 million from EUR291 million a year earlier. Analysts had forecast a rise to EUR305 million, according to FactSet.

Net sales totaled EUR9.71 billion, up 5% from a year earlier, short of analysts' expectations for EUR9.81 billion. Sales growth was a healthy 2.8% in the U.S. and a modest 1.2% in the Netherlands.

Underlying margin dropped to 4.3% from 4.6% and operating result was down 6.3% to EUR416 million.

Ahold said it is on target to deliver EUR350 million in cost savings for the next three years.

In the coming quarters, Ahold's sales and profit will benefit from the consolidation of its recent acquisitions: online retailer Bol.com and 82 stores in the Netherlands from Jumbo.

Delhaize last month swung to a first-quarter net loss, which it attributed to charges related to store closures in the U.S. under its Food Lion brand, as well as openings under its discount Bottom Dollar chain. Its volumes have taken a tumble after it raised prices at Food Lion in an effort to pass on cost inflation to customers, but improved in the first quarter from the fourth quarter of 2011. The Belgian company said underlying operating profit is this year expected to decrease by 15% to 20% at identical exchange rates compared with 2011--far below market expectations.

Ahold is in the process of putting its EUR2.6-billion cash pile to better use, with a focus on organic growth and bolt-on acquisitions. The acquisition of Bol.com, announced in February and completed in May, was an important step. It also aims to open a fifth store in Belgium, aiming for 10 by the end of 2012 and 50 in the next five years. It will open its first German store in the third quarter.

Ahold's shares closed at EUR9.59 on Tuesday, valuing the company at EUR10.5 billion.

Write to Robert van den Oever at robert.vandenoever@dowjones.com

(END) Dow Jones Newswires

June 06, 2012 14:51 ET (18:51 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
20 jun
GEN
Et gammelt indlæg:   Hvis man kigger lidt tilbage i tiden og ser på de kvartalsvise resultater, så l..
36
15 jun
PNDORA
Carnegie´s senste negative udmeldning omkring en lille analyse foretaget blandt nogle franchisetager..
30
16 jun
PNDORA
Som Pandora aktionær er jeg meget tilfreds med ledelsens indsats og de skabte resultater. Ledelsen l..
21
14 jun
 
Jeg har et par gange øffet over niveauet herinde i dette debatforum. I første omgang skrev jeg til b..
18
18 jun
PNDORA
              Jeg har lavet en fuld analyse på Pandora, som er en blanding af en regnskabs-analyse o..
17
20 jun
GEN
Hold da kæft, du er godt nok en sur (gammel ?) mand......
14
16 jun
VELO
Her er mit bud på begivenheder og dato for disse de næste 200 dage. Det bliver en god jul i år som i..
14
16 jun
VWS
Nu er det jo Vestas der er mindst ramt af prispres, da de selv presser priser ned, da målet er at vi..
14
16 jun
VWS
http://globenewswire.com/news-release/2018/06/15/1525456/0/en/Vestas-secures-442-MW-order-from-Xcel-..
13
19 jun
VWS
https://www.vestas.com/en/media/company-news?n=1763161#!NewsView
12

Novo Nordisk/CSO: Vi står i en unik situation

21-06-2018 13:46:41
Novo Nordisk står i en unik position med diabetespillen oral Semaglutid, som i nye studieresultater giver nogle af verdens bedst sælgende diabetesmidler baghjul.Resultaterne fra de pågældende fase 3-studier overstiger forventningerne hos Novo Nordisks forskningsdirektør, Mads Krogsgaard Thomsen, som ser produktet blive verdens bedste tabletbaserede præparat - og dermed også det bedst sælgende. - D..

Ambu/Nordea: Indleder dækningen med "sælg" - 2020-målet for højt - NY

21-06-2018 09:48:10
Nordea indleder dækningen af Ambu-aktien med anbefalingen "sælg". Banken vurderer blandt andet, at Ambus 2020 mål om et salg på 5 mia. kr. er for højt, og at mængden af tidligere opjusteringer har sendt forventningerne op til uholdbare niveauer.Det skriver banken i en analyse.Ambus indtræden i gastrointestinal (GI) endoskopi, hvor Ambu udvikler udstyr til eksempelvis at kunne lave en kikkertunders..

Aktier/tendens: Novo og Chr. Hansen i fokus fra start

21-06-2018 08:19:54
Stærke tendenser for de amerikanske aktier ventes torsdag at sende positive vibrationer ind over aktiemarkederne i Europa, hvor en "dark horse" dog er markedets reaktion på den nedjustering, som den tyske bilgigant Daimler kom med onsdag aften. - Det ser ud til, at vi får lov til at starte lidt bedre op, end man ellers kan frygte, når der er så meget usikkerhed derude. En af de ting, som bliver sp..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Novo og Chr. Hansen i fokus fra start
2
Novo/Sydbank: Flotte data kan sikre høj pris til ny diabetespille - NY
3
Onsdagens aktier: Rekord-Ambu satte C25 til vægs
4
Novo Nordisk/CSO: Vi står i en unik situation
5
Novo/Jefferies: Spår stadig milliardsalg af oral Semaglutid

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. juni 2018 16:19:26
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB3 - 2018-06-21 16:19:26 - 2018-06-21 16:19:26 - 1 - Website: OKAY